Actively Recruiting
Seizure Recurrence After Unprovoked First Seizure
Led by Dr. Gavin Winston · Updated on 2024-10-17
275
Participants Needed
2
Research Sites
161 weeks
Total Duration
On this page
Sponsors
D
Dr. Gavin Winston
Lead Sponsor
C
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
AI-Summary
What this Trial Is About
One in 10 people have a seizure during their life. Usually no cause is identified. Seizures without an identified cause are called unprovoked first seizure (UFS). Most people with UFS do not have further seizures. Being able to predict the risk of more seizures as soon as possible would help doctors decide whether to suggest treatment after UFS. Studies show that seizures are associated with changes in brain structure and function that are difficult to detect with standard assessments but can be detected with advanced techniques. Changes in connections between brain regions are also linked to subtle problems in thinking and mood. The investigators will examine brain connections using detailed brain scans, thinking, and mood in people with UFS and develop an accurate method for calculating the risk of further seizures. 200 adult patients and 75 matched healthy controls from the Halifax and Kingston First Seizure Clinics will undergo cognitive screening assessment of major cognitive domains, MRI imaging including structural scans, resting-state functional MRI (rsfMRI) and diffusion-weighted imaging (DWI), and EEG. Seizure recurrence will be assessed prospectively and a multimodal machine learning model will be trained to predict seizure recurrence at 12 months.
CONDITIONS
Official Title
Seizure Recurrence After Unprovoked First Seizure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 65 years with an unprovoked first seizure seen at First Seizure Clinics in Halifax and Kingston
- Healthy controls matched by age, sex, and education with the same exclusion criteria
You will not qualify if you...
- Age over 65 years
- Diagnosed with non-epileptic events, recurrent seizures, or epilepsy based on clinical assessment or abnormal CT or EEG
- Seizures caused by medication, substance misuse, metabolic causes, or acute symptomatic seizures
- Current use of antiseizure drugs
- Significant central nervous system conditions affecting cognition or brain networks such as progressive neurological disorders or multiple sclerosis
- Previous neurosurgery
- Contraindications to MRI
- Pregnancy or suspected pregnancy without a negative pregnancy test before MRI scanning
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Dalhousie University and Nova Scotia Health Authority
Halifax, Nova Scotia, Canada
Actively Recruiting
2
Queen's University and Kingston Health Sciences Centre
Kingston, Ontario, Canada, K7L 2V7
Actively Recruiting
Research Team
C
Christopher Hlynialuk, MSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here